CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Profile

Company Names

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Addresses

211 E. OSBORN RD., PHOENIX, AZ 85012

2017 W PEORIA AVENUE, PHOENIX, AZ 85029

Phone Numbers

833-336-7636
(602) 680-7439

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$22,502,279.00

Number of Funding Rounds:

17
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
17
2022-05-03 
$17,000,001.00 
$17,000,001.00 
$0.00 
Equity 
16
2021-08-11 
$3,787,750.00 
$4,456,176.00 
$668,426.00 
Debt 
15
2018-09-13 
$509,028.00 
$678,704.00 
$169,676.00 
Debt 
14
2018-03-15 
$48,000.00 
$48,000.00 
$0.00 
Debt 
13
2018-03-13 
$115,000.00 
$115,000.00 
$0.00 
Debt 
12
2018-02-27 
$27,500.00 
$27,500.00 
$0.00 
Debt 
11
2018-02-15 
$53,000.00 
$53,000.00 
$0.00 
Debt 
10
2018-01-17 
$44,000.00 
$44,000.00 
$0.00 
Debt 
9
2017-12-15 
$30,000.00 
$30,000.00 
$0.00 
Debt 
8
2017-12-01 
$58,000.00 
$58,000.00 
$0.00 
Debt 
7
2017-08-31 
$55,000.00 
$55,000.00 
$0.00 
Debt 
6
2017-05-08 
$55,000.00 
$55,000.00 
$0.00 
Debt 
5
2017-05-05 
$115,000.00 
$115,000.00 
$0.00 
Debt 
4
2017-05-02 
$405,000.00 
$405,000.00 
$0.00 
Debt 
3
2017-04-13 
$100,000.00 
$100,000.00 
$0.00 
Debt 
2
2017-03-23 
$100,000.00 
$100,000.00 
$0.00 
Equity 
1
2016-05-18 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DONALD 
 
DICKERSON 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
H. 
FINGER 
DIRECTOR
ANNETTE 
 
MARLEAU 
DIRECTOR, EXECUTIVE OFFICER
SUSAN 
 
SNOW 
DIRECTOR
BRUCE 
S. 
URDANG 
DIRECTOR
TIMOTHY 
 
WARBINGTON 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-05-03 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2021-08-11 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-09-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-03-15 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-03-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-02-27 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-01-17 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2017-12-15 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Debt 
2018-02-15 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-12-01 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-08-31 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-05-05 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-05-08 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-05-02 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2017-04-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2017-03-23 
D
BIOTECHNOLOGY 
[9995] 
NO REVENUES 
Equity 
2016-05-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
ROTH CAPITAL PARTNERS
ROTH CAPITAL PARTNERS
NONE
NONE
ROTH CAPITAL PARTNERS